Literature DB >> 2487130

The impact of adolescent sexual victimization: standardized measures of anxiety, depression, and behavioral deviancy.

C A Gidycz1, M P Koss.   

Abstract

Standardized measures of depression, anxiety, and behavioral deviancy were administered to a nonclinical sample of 67 high school girls (M age = 16.3; SD = 1.28). In addition, an adolescent version of the Sexual Experiences Survey was administered to assess the history of peer sexual victimization. In this sample, 55.0% of the girls had experienced at least one sexual victimization, including 7.5% of them who had experienced completed forcible rape. Data were analyzed via multivariate analysis of variance and multiple regression. Sexually victimized girls scored significantly higher than nonvictimized girls on the Trait Anxiety Index and the Beck Depression Inventory, but not on the Antisocial Index of the Jesness Inventory. The extent of victimization contributed significantly to the prediction of both the depression score and the anxiety score. The clinical significance of the reported symptoms is discussed. Although the study was not based on a probability sample, the prevalence of rape was consistent with existing literature. Because the sample was limited to girls who have remained involved in social systems, the measured symptoms probably are a conservative estimate of retrospectively measured postassault standardized test scores among sexually victimized adolescents.

Entities:  

Mesh:

Year:  1989        PMID: 2487130

Source DB:  PubMed          Journal:  Violence Vict        ISSN: 0886-6708


  2 in total

1.  Impact of sexual coercion on romantic experiences of adolescents and young adults.

Authors:  Charlene Collibee; Wyndol Furman
Journal:  Arch Sex Behav       Date:  2014-02-12

2.  Prediction of depressive distress in a community sample of women: the role of sexual orientation.

Authors:  Alicia K Matthews; Tonda L Hughes; Timothy Johnson; Lisa A Razzano; Roberta Cassidy
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.